Author:
Abramova O. B.,Kaplan M. A.,Grin M. A.,Yuzhakov V. V.,Suvorov N. V.,Mironov A. F.,Drozhzhina V. V.,Churikova T. P.,Kozlovtseva E. A.,Bandurko L. N.,Yakovleva N. D.,Ivanov S. A.,Kaprin A. D.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference8 articles.
1. Burmistrova NV, Drozhzhina VV, Kaplan MA, Yuzhakov VV, Bandurko LN, Tsyganova MG, Ivanov SA, Arkhipova LM, Abramova OB. Study of efficiency of photodynamic therapy of Earlich carcinoma mice with intravenous introduction of photosensibilizer of liposomal boronated chlorine E6. Radiats. Risk. 2019;28(4):96-107. doi: https://doi.org/10.21870/0131-3878-2019-28-4-96-107. Russian.
2. Grin MA, Suvorov NV, Machulkin AE, Plotnikova EA, Yakubovskaya RI, Mazhuga AG, Mironov AF, Filonenko EV. Patent RU No. 2670087. Photosensitizer for photodynamic therapy of prostate cancer and method for manufacturing thereof. Bull. No. 29. Published October 18, 2018.
3. Bařinka C, Rojas C, Slusher B, Pomper M. Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer. Curr. Med. Chem. 2012;19(6):856-870. doi: https://doi.org/10.2174/092986712799034888
4. Davis MI, Bennett MJ, Thomas LM, Bjorkman PJ. Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proc. Natl Acad. Sci. USA. 2005;102(17):5981-5986. doi: https://doi.org/10.1073/pnas.0502101102
5. Nimmagadda S, Pullambhatla M, Chen Y, Parsana P, Lisok A, Chatterjee S, Mease R, Rowe SP, Lupold S, Pienta KJ, Pomper MG. Low-level endogenous PSMA expression in nonprostatic tumor xenografts is sufficient for in vivo tumor targeting and imaging. J. Nucl. Med. 2018;59(3):486-493. doi: https://doi.org/10.2967/jnumed.117.191221
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献